BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 25740983)

  • 1. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
    Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
    J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
    Shinozaki A; Sakatani T; Ushiku T; Hino R; Isogai M; Ishikawa S; Uozaki H; Takada K; Fukayama M
    Cancer Res; 2010 Jun; 70(11):4719-27. PubMed ID: 20484038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD.
    Kim H; Choi H; Lee SK
    Cancer Lett; 2015 Jan; 356(2 Pt B):733-42. PubMed ID: 25449437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
    Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
    Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.
    Zhang J; Huang T; Zhou Y; Cheng ASL; Yu J; To KF; Kang W
    J Cell Mol Med; 2018 Jan; 22(1):38-45. PubMed ID: 28990284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma.
    Kim DN; Chae HS; Oh ST; Kang JH; Park CH; Park WS; Takada K; Lee JM; Lee WK; Lee SK
    J Virol; 2007 Jan; 81(2):1033-6. PubMed ID: 17079300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells.
    Tsai CY; Liu YY; Liu KH; Hsu JT; Chen TC; Chiu CT; Yeh TS
    J Gastroenterol Hepatol; 2017 Jan; 32(1):82-91. PubMed ID: 27144885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells.
    Marquitz AR; Mathur A; Chugh PE; Dittmer DP; Raab-Traub N
    J Virol; 2014 Jan; 88(2):1389-93. PubMed ID: 24227849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
    Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY
    Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.
    Wang D; Zeng Z; Zhang S; Xiong F; He B; Wu Y; Li W; Tang L; Wei F; Xiang B; Li Z; Zhou Y; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C
    FASEB J; 2020 Jun; 34(6):8012-8027. PubMed ID: 32306460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.
    Kang BW; Choi Y; Kwon OK; Lee SS; Chung HY; Yu W; Bae HI; Seo AN; Kang H; Lee SK; Jeon SW; Hur K; Kim JG
    Oncotarget; 2017 Feb; 8(9):14988-14994. PubMed ID: 28122341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis.
    Giudice A; D'Arena G; Crispo A; Tecce MF; Nocerino F; Grimaldi M; Rotondo E; D'Ursi AM; Scrima M; Galdiero M; Ciliberto G; Capunzo M; Franci G; Barbieri A; Bimonte S; Montella M
    Oxid Med Cell Longev; 2016; 2016():6021934. PubMed ID: 26977250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.
    Hooykaas MJ; Kruse E; Wiertz EJ; Lebbink RJ
    BMC Genomics; 2016 Aug; 17():644. PubMed ID: 27531524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.
    Wang M; Yu F; Wu W; Wang Y; Ding H; Qian L
    Int J Biol Sci; 2018; 14(5):565-576. PubMed ID: 29805308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
    Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
    Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.